IME Medical Electrospinning secured € 3 million in new financing from Dutch VCs Borski Fund, Lumana Invest, TIIN Capital and from Rabobank to further expand its Medispin XL production platform
Summary
Ramon Solberg, Founder and together with Judith Heikoop, Managing Director of IME Medical Electrospinning, adds: "This new successful financing round enables us to further capitalize on our scientific and technical findings over the past decade, growing our product portfolio from regenerative medtech solutions to the even broader and promising global market for targeted drug delivery solutions." Human cells recognize this artificial matrix (scaffold) as the bodys own facilitating the repair of the damaged tissue for heart valves, blood vessels, nerves, tendons, skin and bone etc. The MediSpin™ XL platform has been developed specifically for MedTech industrial manufacturing of medical devices and is now also suitable for pharmaceutical drug delivery applicaitons and ensures the firm control of the crucial parameters of the electrospinning process, leading to identical and consistent end-products. It invests in female entrepreneurs because it wants to build good companies with them, because their talent needs to be better utilized, because Borski Fund is their natural partner, because is has the network that matters to them. As entrepreneurial investors, TIIN Capital accelerates growth-oriented companies with active growth and buy & build strategies, where innovative entrepreneurship is central to be able to take the next step.